Why Verastem Shares Are Trading Higher Today
Verastem Inc (NASDAQ: VSTM) is trading higher Monday after the company announced updated investigator-sponsored Phase 1/2 FRAME study data of VS-6766 with defactinib in low-grade serous ovarian cancer showing "encouraging response rates and progression-free survival."
